Krisis Hipertensi
Published on September 22, 2026
Risk Factors
Chronic hypertension with medication non-adherence (most common), renal artery stenosis, pheochromocytoma, pre-eclampsia/eclampsia, cocaine or amphetamine use, withdrawal of clonidine or beta-blockers, primary hyperaldosteronism
Etiology
Abrupt rise in systemic vascular resistance overwhelming the body's autoregulatory mechanisms, leading to endothelial injury and a self-perpetuating cycle of vascular damage
Presentation
Severe headache, visual disturbances, chest pain, dyspnea, altered mental status, focal neurological deficits, or oliguria in a patient with BP typically >180/120 mmHg
Classic Exam
Retinal hemorrhages, exudates, or papilledema on fundoscopy; S3/S4 gallop or pulmonary crackles; focal neuro deficits; asymmetric pulses (aortic dissection)
Diagnostics
Elevated creatinine, proteinuria, hematuria, schistocytes on peripheral smear (microangiopathic hemolytic anemia), troponin elevation, ECG with LVH or ischemic changes, CT head showing hemorrhage or edema
Management
Emergency: IV antihypertensives (nicardipine, labetalol, nitroprusside); reduce MAP by no more than 25% in the first hour. Urgency: oral agents (captopril, clonidine); outpatient follow-up in 24 to 72 hours
Keywords
"Severely elevated BP with papilledema," "headache with retinal hemorrhages," "non-adherent to medications," "flash pulmonary edema," "chest pain with tearing quality and BP differential between arms"
01Pathophysiology
Hypertensive crisis occurs when arterial blood pressure rises to a level that exceeds the capacity of the body's normal autoregulatory mechanisms. Under normal conditions, organs such as the brain, kidneys, and heart maintain constant perfusion across a range of mean arterial pressures (roughly 60 to 150 mmHg in normotensive individuals) by adjusting arteriolar tone. In chronically hypertensive patients, this autoregulatory curve is shifted to the right, meaning their organs tolerate higher pressures but are also more vulnerable to ischemia if pressure drops too quickly. This rightward shift is critical to understanding why aggressive BP lowering is dangerous.
When blood pressure surges beyond the upper limit of autoregulation, the initial response is intense arteriolar vasoconstriction. If pressure continues to rise, this compensatory constriction fails, and the result is "breakthrough" vasodilation in some vascular beds and persistent constriction in others. The endothelium sustains direct mechanical injury, triggering a cascade: platelet aggregation, fibrin deposition, and fibrinoid necrosis of arteriolar walls. This endothelial damage activates the renin-angiotensin-aldosterone system (RAAS), which causes further vasoconstriction and sodium retention, creating a vicious cycle of escalating pressure and worsening vascular injury.
The downstream consequences depend on which organ beds are affected. In the brain, disruption of the blood-brain barrier leads to hypertensive encephalopathy with vasogenic edema (seen on MRI as posterior reversible encephalopathy syndrome, or PRES). In the kidneys, fibrinoid necrosis of afferent arterioles produces acute kidney injury with hematuria, proteinuria, and sometimes a thrombotic microangiopathy (TMA) pattern with schistocytes on blood smear. In the heart, the extreme afterload increase leads to acute left ventricular failure and flash pulmonary edema, or may precipitate acute coronary syndrome in patients with underlying coronary artery disease. In the vasculature, the shearing forces on the aortic wall can initiate or propagate an aortic dissection.
The key teaching point is that the rate of BP rise matters more than the absolute number. A previously normotensive pregnant woman can develop eclampsia at 160/110 mmHg, while a chronically hypertensive patient may tolerate 200/120 mmHg without immediate end-organ injury. The exam tests whether you understand that end-organ damage, not the blood pressure reading itself, is what defines a hypertensive emergency.
02Classification and Clinical Manifestation
Hypertensive Urgency
Blood Pressure
Typically >180/120 mmHg
End-Organ Damage
Absent
Clinical Features
Severe headache, anxiety, epistaxis, shortness of breath; no objective evidence of acute target organ injury
Setting
Outpatient, observation
Hypertensive Emergency
Blood Pressure
Typically >180/120 mmHg (can be lower in pregnancy or acute settings)
End-Organ Damage
Present
Clinical Features
See organ-based breakdown below
Setting
ICU, continuous monitoring
Classification | Blood Pressure | End-Organ Damage | Clinical Features | Setting |
|---|---|---|---|---|
Hypertensive Urgency | Typically >180/120 mmHg | Absent | Severe headache, anxiety, epistaxis, shortness of breath; no objective evidence of acute target organ injury | Outpatient, observation |
Hypertensive Emergency | Typically >180/120 mmHg (can be lower in pregnancy or acute settings) | Present | See organ-based breakdown below | ICU, continuous monitoring |
Organ-Based Manifestations of Hypertensive Emergency
Brain
Clinical Syndrome
Hypertensive encephalopathy
Key Findings
Headache, confusion, visual disturbance, seizures, nausea/vomiting; MRI shows posterior white matter edema (PRES)
Brain
Clinical Syndrome
Hemorrhagic stroke
Key Findings
Sudden focal neuro deficit, altered consciousness; CT head shows intracerebral hemorrhage
Brain
Clinical Syndrome
Ischemic stroke
Key Findings
Focal neuro deficit; CT head initially normal, then evolving infarct
Heart
Clinical Syndrome
Acute coronary syndrome
Key Findings
Chest pain, troponin elevation, ST changes on ECG
Heart
Clinical Syndrome
Acute decompensated heart failure / Flash pulmonary edema
Key Findings
Severe dyspnea, orthopnea, bilateral crackles, S3 gallop, bilateral pulmonary infiltrates on CXR
Aorta
Clinical Syndrome
Aortic dissection
Key Findings
Sudden "tearing" chest/back pain, BP differential >20 mmHg between arms, widened mediastinum on CXR, new aortic regurgitation murmur
Kidney
Clinical Syndrome
Acute hypertensive nephrosclerosis
Key Findings
Rising creatinine, hematuria, proteinuria, oliguria
Blood
Clinical Syndrome
Thrombotic microangiopathy
Key Findings
Schistocytes on peripheral smear, elevated LDH, low haptoglobin, thrombocytopenia
Eye
Clinical Syndrome
Hypertensive retinopathy (Grade III/IV)
Key Findings
Retinal hemorrhages, exudates (Grade III); papilledema (Grade IV)
Uterus/Placenta
Clinical Syndrome
Eclampsia / Severe pre-eclampsia
Key Findings
Seizures, proteinuria, elevated LFTs, thrombocytopenia (HELLP), BP may be >160/110
Target Organ | Clinical Syndrome | Key Findings |
|---|---|---|
Brain | Hypertensive encephalopathy | Headache, confusion, visual disturbance, seizures, nausea/vomiting; MRI shows posterior white matter edema (PRES) |
Brain | Hemorrhagic stroke | Sudden focal neuro deficit, altered consciousness; CT head shows intracerebral hemorrhage |
Brain | Ischemic stroke | Focal neuro deficit; CT head initially normal, then evolving infarct |
Heart | Acute coronary syndrome | Chest pain, troponin elevation, ST changes on ECG |
Heart | Acute decompensated heart failure / Flash pulmonary edema | Severe dyspnea, orthopnea, bilateral crackles, S3 gallop, bilateral pulmonary infiltrates on CXR |
Aorta | Aortic dissection | Sudden "tearing" chest/back pain, BP differential >20 mmHg between arms, widened mediastinum on CXR, new aortic regurgitation murmur |
Kidney | Acute hypertensive nephrosclerosis | Rising creatinine, hematuria, proteinuria, oliguria |
Blood | Thrombotic microangiopathy | Schistocytes on peripheral smear, elevated LDH, low haptoglobin, thrombocytopenia |
Eye | Hypertensive retinopathy (Grade III/IV) | Retinal hemorrhages, exudates (Grade III); papilledema (Grade IV) |
Uterus/Placenta | Eclampsia / Severe pre-eclampsia | Seizures, proteinuria, elevated LFTs, thrombocytopenia (HELLP), BP may be >160/110 |
03Diagnostic Workup
Blood pressure (both arms)
Purpose
Confirm severity; detect asymmetry
Key Findings
>180/120 mmHg; >20 mmHg difference between arms suggests aortic dissection
Fundoscopic exam
Purpose
Assess for hypertensive retinopathy
Key Findings
Hemorrhages, exudates, papilledema (confirms emergency)
Basic metabolic panel (BMP)
Purpose
Assess renal function and electrolytes
Key Findings
Elevated creatinine, hyperkalemia, low bicarbonate
Urinalysis
Purpose
Screen for renal end-organ damage
Key Findings
Proteinuria, hematuria, RBC casts
CBC with peripheral smear
Purpose
Evaluate for microangiopathic hemolytic anemia
Key Findings
Schistocytes, thrombocytopenia
Troponin
Purpose
Assess for myocardial injury
Key Findings
Elevation indicates ACS or demand ischemia
ECG
Purpose
Cardiac evaluation
Key Findings
LVH, ST-T wave changes, ischemia pattern
Chest X-ray
Purpose
Cardiac silhouette, pulmonary edema, mediastinum
Key Findings
Cardiomegaly, pulmonary vascular congestion, widened mediastinum
CT head (non-contrast)
Purpose
If neurological symptoms present
Key Findings
Intracerebral hemorrhage, edema, infarct
CT angiography (chest/abdomen)
Purpose
If aortic dissection suspected
Key Findings
Intimal flap, true and false lumen
Urine drug screen
Purpose
If sympathomimetic use suspected
Key Findings
Positive for cocaine, amphetamines
Plasma metanephrines / 24-hr urine catecholamines
Purpose
If pheochromocytoma suspected
Key Findings
Elevated metanephrines
Renal artery Doppler / CTA renal arteries
Purpose
If renovascular hypertension suspected
Key Findings
Renal artery stenosis
Test | Purpose | Key Findings |
|---|---|---|
Blood pressure (both arms) | Confirm severity; detect asymmetry | >180/120 mmHg; >20 mmHg difference between arms suggests aortic dissection |
Fundoscopic exam | Assess for hypertensive retinopathy | Hemorrhages, exudates, papilledema (confirms emergency) |
Basic metabolic panel (BMP) | Assess renal function and electrolytes | Elevated creatinine, hyperkalemia, low bicarbonate |
Urinalysis | Screen for renal end-organ damage | Proteinuria, hematuria, RBC casts |
CBC with peripheral smear | Evaluate for microangiopathic hemolytic anemia | Schistocytes, thrombocytopenia |
Troponin | Assess for myocardial injury | Elevation indicates ACS or demand ischemia |
ECG | Cardiac evaluation | LVH, ST-T wave changes, ischemia pattern |
Chest X-ray | Cardiac silhouette, pulmonary edema, mediastinum | Cardiomegaly, pulmonary vascular congestion, widened mediastinum |
CT head (non-contrast) | If neurological symptoms present | Intracerebral hemorrhage, edema, infarct |
CT angiography (chest/abdomen) | If aortic dissection suspected | Intimal flap, true and false lumen |
Urine drug screen | If sympathomimetic use suspected | Positive for cocaine, amphetamines |
Plasma metanephrines / 24-hr urine catecholamines | If pheochromocytoma suspected | Elevated metanephrines |
Renal artery Doppler / CTA renal arteries | If renovascular hypertension suspected | Renal artery stenosis |
The best initial step in evaluating any patient presenting with severely elevated blood pressure is to determine whether end-organ damage is present. This is done at the bedside through a focused history and physical examination. You are looking for symptoms of encephalopathy (confusion, visual changes, seizures), cardiac involvement (chest pain, dyspnea), and renal injury (oliguria, hematuria). A fundoscopic exam is a rapid, noninvasive bedside test that can immediately classify the situation: the presence of retinal hemorrhages, cotton-wool spots (exudates), or papilledema confirms a hypertensive emergency.
Once you suspect end-organ damage, you simultaneously initiate treatment (do not delay for labs) and order the baseline workup: BMP, CBC with peripheral smear, troponin, urinalysis, ECG, and chest X-ray. These tests collectively screen the three most commonly affected organ systems (brain, heart, kidney) and evaluate for microangiopathic hemolytic anemia.
If the patient has neurological symptoms, a non-contrast CT of the head is the best initial imaging test to rule out hemorrhagic stroke. If the CT is negative and you suspect hypertensive encephalopathy, an MRI with FLAIR sequences is the most accurate test, revealing posterior white matter edema consistent with PRES.
If the patient has tearing chest or back pain with a blood pressure differential between arms, the workup shifts to ruling out aortic dissection. A CXR may show a widened mediastinum, but the CT angiography of the chest is the confirmatory test. Transesophageal echocardiography (TEE) is an alternative, particularly in unstable patients who cannot be transported to CT.
If no obvious precipitant is identified, consider secondary causes of hypertension, particularly in young patients or those with refractory hypertension. Plasma free metanephrines screen for pheochromocytoma; renal artery Doppler or CT angiography screens for renovascular disease.
A urine drug screen should be obtained whenever cocaine or amphetamine use is clinically suspected, as it changes the treatment approach.
04Management and Treatment
Hypertensive Emergency (general)
Goal
Controlled reduction
First-Line Agent(s)
Nicardipine IV or Labetalol IV
BP Target
Reduce MAP by no more than 25% in the first hour; then to ~160/100 mmHg over the next 2 to 6 hours; then gradually to normal over 24 to 48 hours
Aortic Dissection
Goal
Rapid, aggressive reduction
First-Line Agent(s)
Esmolol IV (first) + Nicardipine IV (after beta-blockade)
BP Target
SBP <120 mmHg and HR <60 bpm within 20 minutes
Acute Coronary Syndrome
Goal
Reduce afterload, relieve ischemia
First-Line Agent(s)
Nitroglycerin IV + Labetalol IV
BP Target
SBP reduction by ~15 to 20%
Flash Pulmonary Edema
Goal
Reduce preload and afterload
First-Line Agent(s)
Nitroglycerin IV or Nitroprusside IV + loop diuretic
BP Target
Symptom-guided; reduce SBP by ~15 to 20%
Hypertensive Encephalopathy / PRES
Goal
Controlled reduction
First-Line Agent(s)
Nicardipine IV or Labetalol IV
BP Target
Reduce MAP by 20 to 25% in first hour
Hemorrhagic Stroke
Goal
Prevent hematoma expansion
First-Line Agent(s)
Nicardipine IV or Labetalol IV
BP Target
Target SBP <140 mmHg within 1 hour
Ischemic Stroke (no thrombolytics)
Goal
Permissive hypertension
First-Line Agent(s)
Treat only if >220/120 mmHg
BP Target
Reduce by ~15%
Ischemic Stroke (receiving thrombolytics)
Goal
Safe thrombolysis window
First-Line Agent(s)
Nicardipine IV or Labetalol IV
BP Target
Maintain <185/110 before and <180/105 after tPA
Eclampsia / Severe Pre-eclampsia
Goal
Prevent maternal seizure and stroke
First-Line Agent(s)
IV Labetalol or IV Hydralazine + Magnesium sulfate (for seizure prophylaxis)
BP Target
Target <140/90 mmHg
Cocaine-induced Crisis
Goal
Reverse alpha-mediated vasoconstriction
First-Line Agent(s)
Benzodiazepines first; then Phentolamine or Nicardipine
BP Target
Symptom-guided reduction
Pheochromocytoma Crisis
Goal
Alpha-blockade before beta-blockade
First-Line Agent(s)
Phentolamine IV
BP Target
Symptom-guided reduction
Hypertensive Urgency
Goal
Gradual reduction
First-Line Agent(s)
Oral captopril (25 mg), oral clonidine (0.1 to 0.2 mg), or oral labetalol (200 mg)
BP Target
Reduce over 24 to 48 hours; outpatient follow-up within 72 hours
Scenario | Goal | First-Line Agent(s) | BP Target |
|---|---|---|---|
Hypertensive Emergency (general) | Controlled reduction | Nicardipine IV or Labetalol IV | Reduce MAP by no more than 25% in the first hour; then to ~160/100 mmHg over the next 2 to 6 hours; then gradually to normal over 24 to 48 hours |
Aortic Dissection | Rapid, aggressive reduction | Esmolol IV (first) + Nicardipine IV (after beta-blockade) | SBP <120 mmHg and HR <60 bpm within 20 minutes |
Acute Coronary Syndrome | Reduce afterload, relieve ischemia | Nitroglycerin IV + Labetalol IV | SBP reduction by ~15 to 20% |
Flash Pulmonary Edema | Reduce preload and afterload | Nitroglycerin IV or Nitroprusside IV + loop diuretic | Symptom-guided; reduce SBP by ~15 to 20% |
Hypertensive Encephalopathy / PRES | Controlled reduction | Nicardipine IV or Labetalol IV | Reduce MAP by 20 to 25% in first hour |
Hemorrhagic Stroke | Prevent hematoma expansion | Nicardipine IV or Labetalol IV | Target SBP <140 mmHg within 1 hour |
Ischemic Stroke (no thrombolytics) | Permissive hypertension | Treat only if >220/120 mmHg | Reduce by ~15% |
Ischemic Stroke (receiving thrombolytics) | Safe thrombolysis window | Nicardipine IV or Labetalol IV | Maintain <185/110 before and <180/105 after tPA |
Eclampsia / Severe Pre-eclampsia | Prevent maternal seizure and stroke | IV Labetalol or IV Hydralazine + Magnesium sulfate (for seizure prophylaxis) | Target <140/90 mmHg |
Cocaine-induced Crisis | Reverse alpha-mediated vasoconstriction | Benzodiazepines first; then Phentolamine or Nicardipine | Symptom-guided reduction |
Pheochromocytoma Crisis | Alpha-blockade before beta-blockade | Phentolamine IV | Symptom-guided reduction |
Hypertensive Urgency | Gradual reduction | Oral captopril (25 mg), oral clonidine (0.1 to 0.2 mg), or oral labetalol (200 mg) | Reduce over 24 to 48 hours; outpatient follow-up within 72 hours |
General Principles for Hypertensive Emergency
The overarching rule is controlled reduction, not normalization. The goal is to lower the MAP by no more than 25% in the first hour. This is because chronically hypertensive patients have a rightward-shifted autoregulatory curve, and dropping the BP too quickly can precipitate watershed cerebral infarction, coronary ischemia, or acute kidney injury. After the initial controlled reduction, you aim for approximately 160/100 mmHg over the next 2 to 6 hours, followed by gradual normalization over the subsequent 24 to 48 hours.
All hypertensive emergencies require continuous arterial monitoring (ideally via an arterial line) and admission to an intensive care unit.
Nicardipine is a dihydropyridine calcium channel blocker given as a continuous IV infusion. Start at 5 mg/hr and titrate by 2.5 mg/hr every 5 to 15 minutes to a maximum of 15 mg/hr. It has a predictable dose-response curve, does not require bolus dosing, and has minimal reflex tachycardia compared to other vasodilators. It is safe in most clinical scenarios and is considered a first-line agent for most hypertensive emergencies.
Labetalol is a combined alpha- and beta-blocker. It can be given as an IV bolus of 20 mg, followed by escalating boluses of 40 to 80 mg every 10 minutes (up to a cumulative dose of 300 mg), or as a continuous infusion at 0.5 to 2 mg/min. It reduces heart rate and blood pressure simultaneously, making it useful when tachycardia accompanies the crisis. It is contraindicated in patients with severe bradycardia, heart block greater than first degree, decompensated heart failure, asthma, or cocaine use (though its alpha-blocking component partially offsets the risk, pure avoidance of beta-blockers is the standard teaching for cocaine-related emergencies).
Sodium Nitroprusside is a potent arteriolar and venous dilator given at 0.25 to 0.5 mcg/kg/min, titrated every few minutes up to a maximum of 10 mcg/kg/min. Its onset is within seconds and offset is equally rapid, providing fine-tuned control. However, it carries the risk of cyanide toxicity with prolonged use (generally >48 to 72 hours or at high doses), manifesting as lactic acidosis, altered mental status, and seizures. It also raises intracranial pressure, making it a poor choice in patients with stroke or encephalopathy. Monitor cyanide and thiocyanate levels during extended infusions.
Fenoldopam is a dopamine D1 receptor agonist at 0.1 to 0.3 mcg/kg/min IV, titrated every 15 minutes. It uniquely improves renal perfusion and is a reasonable choice in patients with acute kidney injury.
Clevidipine is an ultra-short-acting dihydropyridine calcium channel blocker, started at 1 to 2 mg/hr IV and titrated by doubling every 90 seconds (max 32 mg/hr). Its half-life is approximately 1 minute, allowing very precise control. It is formulated in a lipid emulsion and is contraindicated in soy or egg allergy, severe aortic stenosis, and defective lipid metabolism.
Scenario-Based Considerations
For aortic dissection, the priority is to reduce both blood pressure and heart rate to decrease aortic wall shear stress. Beta-blockade must be initiated first (esmolol 500 mcg/kg bolus, then 25 to 50 mcg/kg/min infusion; or labetalol IV) to achieve HR <60 bpm before adding a vasodilator. If you give a vasodilator first, the resultant reflex tachycardia increases aortic shear stress and can propagate the dissection. Once the heart rate is controlled, add nicardipine or nitroprusside to reach SBP <120 mmHg. This is the one scenario where aggressive, rapid BP lowering is indicated.
For acute coronary syndrome, IV nitroglycerin (starting at 5 mcg/min, titrated by 5 mcg/min every 3 to 5 minutes) is preferred because it reduces preload, relieves coronary vasospasm, and decreases myocardial oxygen demand. Add labetalol for rate and pressure control. Avoid nitroprusside (coronary steal phenomenon).
For eclampsia or severe pre-eclampsia, use IV labetalol (20 mg bolus, then 40 to 80 mg every 10 min) or IV hydralazine (5 to 10 mg every 20 minutes). Magnesium sulfate (4 to 6 g IV loading dose, then 1 to 2 g/hr maintenance) is given for seizure prophylaxis and treatment, not for blood pressure control. ACE inhibitors, ARBs, and nitroprusside are absolutely contraindicated in pregnancy due to teratogenicity and fetal toxicity.
For cocaine- or amphetamine-induced hypertensive crisis, the first-line treatment is benzodiazepines (diazepam 5 to 10 mg IV or lorazepam 2 mg IV) because the underlying mechanism is sympathetic overstimulation, and anxiolysis alone often substantially reduces BP. If further BP reduction is needed, add phentolamine (5 to 15 mg IV bolus) or nicardipine. Do not give beta-blockers as monotherapy in cocaine toxicity because blocking beta-2 mediated vasodilation leaves alpha-mediated vasoconstriction unopposed, potentially worsening hypertension and coronary vasospasm. This is one of the most commonly tested points on the exam.
For pheochromocytoma crisis, the principle is the same: alpha-blockade (phentolamine) must come before beta-blockade. If you give a beta-blocker first, you again risk unopposed alpha stimulation and a paradoxical rise in BP.
Hypertensive Urgency
These patients have severely elevated BP but no evidence of end-organ damage. They do not need IV medications or ICU admission. Management consists of oral antihypertensives such as captopril 25 mg PO, clonidine 0.1 to 0.2 mg PO, or labetalol 200 mg PO, with the goal of gradually reducing BP over 24 to 48 hours. The most important step is to identify why the patient's BP is uncontrolled (most commonly non-adherence to their chronic regimen), restart or adjust their home medications, and arrange close outpatient follow-up within 24 to 72 hours.
05Differential Diagnosis and Distractors
Panic attack / Anxiety disorder
Why It Is Similar
Elevated BP, headache, palpitations, diaphoresis
Key Discriminator
No end-organ damage; BP normalizes with anxiolysis; no retinal changes; symptoms resolve spontaneously
Pheochromocytoma
Why It Is Similar
Episodic severe hypertension, headache, diaphoresis, palpitations (classic triad)
Key Discriminator
Episodic rather than sustained; elevated plasma metanephrines and urinary catecholamines; adrenal mass on imaging
Thyroid storm
Why It Is Similar
Tachycardia, hypertension, agitation, altered mental status
Key Discriminator
Fever, goiter, exophthalmos, atrial fibrillation, elevated free T4, suppressed TSH; systolic hypertension with wide pulse pressure
Cocaine or amphetamine intoxication
Why It Is Similar
Severely elevated BP, chest pain, agitation, diaphoresis
Key Discriminator
Positive urine drug screen; dilated pupils; history or signs of illicit drug use; younger patient without known hypertension
Aortic dissection
Why It Is Similar
Severe hypertension, chest pain
Key Discriminator
"Tearing" quality pain radiating to the back; BP asymmetry between arms; widened mediastinum on CXR; intimal flap on CTA
Acute stroke (ischemic)
Why It Is Similar
Elevated BP with neurological deficit
Key Discriminator
The hypertension in ischemic stroke is often reactive (Cushing response) and should not be aggressively treated unless thresholds are exceeded; the focal deficit pattern follows a vascular territory
Acute glomerulonephritis
Why It Is Similar
Hypertension with hematuria and proteinuria
Key Discriminator
Often follows a streptococcal infection (post-strep GN); low complement C3; RBC casts on UA; hypertension is secondary to volume overload, not a primary vascular crisis
TTP-HUS
Why It Is Similar
Schistocytes, thrombocytopenia, renal failure (overlaps with hypertensive TMA)
Key Discriminator
Classic pentad: fever, thrombocytopenia, microangiopathic hemolytic anemia, renal failure, neurological symptoms; ADAMTS13 activity <10% confirms TTP
Differential | Why It Is Similar | Key Discriminator |
|---|---|---|
Panic attack / Anxiety disorder | Elevated BP, headache, palpitations, diaphoresis | No end-organ damage; BP normalizes with anxiolysis; no retinal changes; symptoms resolve spontaneously |
Pheochromocytoma | Episodic severe hypertension, headache, diaphoresis, palpitations (classic triad) | Episodic rather than sustained; elevated plasma metanephrines and urinary catecholamines; adrenal mass on imaging |
Thyroid storm | Tachycardia, hypertension, agitation, altered mental status | Fever, goiter, exophthalmos, atrial fibrillation, elevated free T4, suppressed TSH; systolic hypertension with wide pulse pressure |
Cocaine or amphetamine intoxication | Severely elevated BP, chest pain, agitation, diaphoresis | Positive urine drug screen; dilated pupils; history or signs of illicit drug use; younger patient without known hypertension |
Aortic dissection | Severe hypertension, chest pain | "Tearing" quality pain radiating to the back; BP asymmetry between arms; widened mediastinum on CXR; intimal flap on CTA |
Acute stroke (ischemic) | Elevated BP with neurological deficit | The hypertension in ischemic stroke is often reactive (Cushing response) and should not be aggressively treated unless thresholds are exceeded; the focal deficit pattern follows a vascular territory |
Acute glomerulonephritis | Hypertension with hematuria and proteinuria | Often follows a streptococcal infection (post-strep GN); low complement C3; RBC casts on UA; hypertension is secondary to volume overload, not a primary vascular crisis |
TTP-HUS | Schistocytes, thrombocytopenia, renal failure (overlaps with hypertensive TMA) | Classic pentad: fever, thrombocytopenia, microangiopathic hemolytic anemia, renal failure, neurological symptoms; ADAMTS13 activity <10% confirms TTP |
06Traps and High-Yield Pearls
The single most common mistake on questions about hypertensive crisis is treating the number instead of the clinical picture. A blood pressure of 200/115 mmHg with a headache and no other findings is hypertensive urgency and requires oral medications and outpatient follow-up. That same blood pressure with papilledema, rising creatinine, or a troponin elevation is a hypertensive emergency requiring IV medications and ICU admission. Vignettes will try to make you panic about the number itself; the correct approach is always to look for objective evidence of end-organ damage first.
The second major trap is dropping BP too quickly. In most emergencies, reducing MAP by more than 25% in the first hour risks watershed ischemia, particularly in the brain. Many students instinctively want to normalize BP as fast as possible, and the exam will punish this. The notable exception is aortic dissection, where rapid and aggressive lowering to SBP <120 mmHg is essential.
The third frequently tested trap is beta-blocker use in cocaine toxicity. The exam will present a young patient with chest pain, hypertension, and a positive cocaine screen, then offer metoprolol or atenolol as an answer choice. Choosing a beta-blocker in this context leads to unopposed alpha stimulation, worsening the crisis. The correct first-line agent is a benzodiazepine, followed by phentolamine or nicardipine if further BP reduction is needed.
Another commonly tested point is the sequencing of medications in aortic dissection. You must give the beta-blocker (esmolol) before the vasodilator (nicardipine). If the vasodilator is given first, reflex tachycardia increases aortic shear stress and can extend the dissection.
Finally, know the contraindications in pregnancy: ACE inhibitors, ARBs, and nitroprusside are all prohibited. The go-to agents are IV labetalol and IV hydralazine, and magnesium sulfate is for seizure prevention, not for blood pressure control.
The core competency being tested is your ability to recognize end-organ damage, match the clinical scenario to the correct pharmacologic intervention, and understand the physiologic rationale behind BP reduction targets and drug sequencing.